Table of Content

1. Introduction To Transdermal Patch
  1.1 Overview Of Transdermal Patch
  1.2 Relevance Of Transdermal Patch
 
2. Transdermal Patches Classification
  2.1 Single/ Multiple Layer Drug In Adhesive
  2.2 Reservoir Transdermal Patches
  2.3 Matrix Based Transdermal Patches
  2.4 Vapor Patch
  2.5 Active & Passive Patch
 
3. Mechanism Of Transdermal Patch Drug Delivery
  3.1 Properties Of Transdermal Therapeutics
  3.2 Components Of Transdermal Patch
  3.3 Mechanism Of Motion Sickness, Nicotine & Female Contraceptive Transdermal
  Patch
  3.4 Transdermal Patch v/s Traditional Drug Delivery Methods
 
4. Global Transdermal Patch Market Outlook
  4.1 Current Market Scenario
  4.2 Future Market Opportunity
 
5. Global Transdermal Patch Market Trends By Region
  5.1 US
  5.2 Europe
  5.3 China
  5.4 Japan
  5.5 South Korea
  5.6 UK
 
6. Global Patch Clinical Pipeline By Company, Indication & Phase
  6.1 Research
  6.2 Preclinical
  6.3 Phase-I
  6.4 Phase-I/II
  6.5 Phase-II
  6.6 Phase-III
  6.7 Preregistration
  6.8 Registered
 
7. Global Marketed Transdermal Patch Clinical Insight
 
8. Transdermal Patches For Cardiovascular Diseases – Market Availability, Dosage & Price Analysis
  8.1 Nitroglycerin Transdermal Patch
    8.1.1 Nitro-Dur
    8.1.2 Nitro TD Patch A
    8.1.3 Generic Nitroglycerin Transdermal Patch
  8.2 Clonidine Transdermal Patch
    8.2.1 Catapres–TTS
    8.2.2 Generic Clonidine Transdermal Patch
  8.3 Bisoprolol Transdermal Patch (Bisono)
 
9. Transdermal Analgesic Patches - Market Availability, Dosage & Price Analysis
  9.1 Fentanyl Transdermal Patch
    9.1.1 Duragesic/Durogesic
    9.1.2 Durotep MT
    9.1.3 OneDuro
    9.1.4 Generic Fentanyl Transdermal Patch
    9.1.5 Fentos
    9.1.6 Fentadur
    9.1.7 Generic Fentanyl Citrate Transdermal Patch
  9.2 Buprenorphine Transdermal Patch
    9.2.1 Butrans
    9.2.2 Bunov
    9.2.3 Sevodyne
    9.2.4 Transtec
    9.2.5 Generic Buprenorphine Transdermal Patch
  9.3 Diclofenac Transdermal Patch
    9.3.1 Zicthoru
    9.3.2 Flector
 
    9.3.3 Licart
  9.4 Ketoprofen Transdermal Patch (Mohrus)
  9.5 Lidocaine Transdermal Patch
    9.5.1 Versatis
    9.5.2 ZTlido
    9.5.3 Penles
    9.5.4 Rapydan
    9.6 Capsaicin Transdermal Patch (Qutenza)
  9.7 Methyl Salicate Transdermal Patch
    9.7.1 Salonpas
    9.7.2 Tokuhon
  9.8 Glycol Salicylate Transdermal Patch (Tokuhon E)
  9.9 Flurbiprofen Transdermal Patch
    9.9.1 Loqoa
    9.9.2 Yakuban Tape
    9.9.3 Transact Lat
 
10. Transdermal Patch In Hormonal Therapy - Market Availability, Dosage & Price Analysis
  10.1 Estradiol Transdermal Patch
    10.1.1 Alora
    10.1.2 Vivelle-Dot
    10.1.3 Minivelle
    10.1.4 Climara
    10.1.5 Menostar
    10.1.6 FemSeven
    10.1.7 Estrana
    10.1.8 Generic Estradiol Transdermal Patch
  10.2 Testosterone Transdermal Patch (Androderm)
  10.3 Estradiol/ Norethisterone Transdermal Patch
    10.3.1 Xulane/Ortho Evra
    10.3.2 Combipatch
    10.3.3 Menoaid Combi Patch
    10.3.4 Evorel Conti
  10.4 Estradiol/Levonorgestrel Transdermal Patch
  10.5 Ethinyl Estradiol/Levonorgestrel  (Twirla)
 
  10.6 Ethinyl Estradiol/Gestodene (Apleek)
 
11. Transdermal Patches For Neurological Disorders - Market Availability, Dosage & Price Analysis
  11.1 Scopolamine Transdermal Patch (Transderm-Scop)
  11.2 Selegiline Transdermal Patch (Emsam)
  11.3 Methylphenidate Transdermal Patch (Daytrana)
  11.4 Dextroamphetamine Transdermal Patch (Xelstrym)
  11.5 Blonanserin Transdermal Patch (Lonasen)
  11.6 Asenapine Transdermal Patch (Secuado)
  11.7 Rivastigmine Transdermal Patch
    11.7.1 Exelon
    11.7.2 Generic Rivastigmine Transdermal Patch
  11.8 Rotigotine Transdermal Patch (Neupro)
  11.9 Ropinirole Hydrochloride (Haruropi Tape)
  11.10 Donepezil Transdermal Patch (Adlarity)
 
12. Patches For Other Conditions - Market Availability, Dosage & Price Analysis
  12.1 Nicotine Transdermal Patch (Nicoderm CQ/ Nicotinell TTS)
  12.2 Oxybutynin Transdermal Patch (Oxytrol/Kentera)
  12.3 Granisetron Transdermal Patch (Sancuso)
  12.4 Emedastine Transdermal Patch (Allesaga)
  12.5 Fibrin Sealant Transdermal Patch
    12.5.1 Evarrest
    12.5.2 TachoSil
    12.6 5-Aminolevulinic Acid Transdermal Patch (Alacare)
  12.7 Tulobuterol Transdermal Patch
    12.7.1 Tulo-Touch
    12.7.2 Hokunarin
 
13. Global Transdermal Patch Market Dynamics
  13.1 Favorable Market Parameters
  13.2 Commercialization Challenges
 
14. Competitive Landscape
  14.1 AbbVie
  14.2 Bayer HealthCare Pharmaceuticals
  14.3 Corium International
  14.4 Endo Pharmaceuticals
  14.5 Hisamitsu Pharmaceutical
  14.6 Luye Pharma
  14.7 Noven Pharmaceuticals
  14.8 Novartis
  14.9 Purdue Pharma
  14.10 Scilex Pharmaceuticals
  14.11 Searchlight Pharma
  14.12 Somerset Pharmaceuticals
  14.13 Teikoku Seiyaku
  14.14 Teva Pharmaceuticals
  14.15 UCB
  14.16 DURECT Corporation
  14.17 Senju Pharmaceutical
 
 

List of Tables

Table 2-1: Active v/s Passive Transdermal Patch

Table 3-1: Transdermal Patches For Various Disease Indications

Table 9-1: Duragesic - Initial Dose Conversion From Other Opioids
Table 9-2: Butrans – Initial Dose Calculation Using Previous Opioid (Morphine) Dosage

Table 11-1: Daytrana - Dose Increment Pattern For Treatment Of ADHD